These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7851841)

  • 1. Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats.
    Petitjean P; Vloemans M; Barthelmebs M; Stephan D; Grima M; Jund A; Imbs JL
    Fundam Clin Pharmacol; 1994; 8(4):356-65. PubMed ID: 7851841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor.
    Fabris B; Candido R; Carraro M; Fior F; Artero M; Zennaro C; Cattin MR; Fiorotto A; Bortoletto M; Millevoi C; Bardelli M; Faccini L; Carretta R
    Diabetes; 2001 Nov; 50(11):2619-24. PubMed ID: 11679443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.
    Onozato ML; Tojo A; Goto A; Fujita T
    Diabetes Res Clin Pract; 2003 Feb; 59(2):83-92. PubMed ID: 12560157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.
    Graziano MJ; Dethloff LA; Griffin HE; Pegg DG
    Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.
    New JP; Canavan JP; Flyvbjerg A; Hamon G; Bilous RW; Marshall SM
    Diabetologia; 1996 Feb; 39(2):166-71. PubMed ID: 8635668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.
    Jandeleit-Dahm K; Lassila M; Davis BJ; Candido R; Johnston CI; Allen TJ; Burrell LM; Cooper ME
    J Hypertens; 2005 Nov; 23(11):2071-82. PubMed ID: 16208151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
    Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy.
    Mukawa H; Toki Y; Shimauchi A; Matsui H; Morishima I; Okumura K; Ito T; Hayakawa T
    J Hypertens; 1997 Sep; 15(9):1027-32. PubMed ID: 9321751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
    Sen S; Kanter M; Ustundag S; Aktas C; Dogutan H; Yalcin O
    Ren Fail; 2008; 30(10):1023-33. PubMed ID: 19016156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
    Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
    Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
    Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
    J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs.
    Navarro-Cid J; Maeso R; Rodrigo E; Muñoz-García R; Ruilope LM; Lahera V; Cachofeiro V
    Am J Hypertens; 1996 Nov; 9(11):1077-83. PubMed ID: 8931832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
    Kähönen M; Mäkynen H; Wu X; Arvola P; Pekki A; Pörsti I
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which urinary proteins are decreased after angiotensin converting--enzyme inhibition?
    Guidi E; Giglioni A; Cozzi MG; Minetti EE
    Ren Fail; 1998 Mar; 20(2):243-8. PubMed ID: 9574449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal structure and function in rats after suprapharmacologic doses of quinapril, an angiotensin-converting enzyme inhibitor.
    MacDonald JR; Susick RL; Pegg DG; Dominick MA
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):282-9. PubMed ID: 1376798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats.
    Schaison FH; Fernando Ramirez-Gil J; Ciferri S; Bernard M; Baudin B; Mougenot N; Carayon A; Lechat P
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):11-8. PubMed ID: 8797130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic ACE inhibition by quinapril modulates central vasopressinergic system.
    Muders F; Elsner D; Jandeleit K; Bahner U; Kromer EP; Kirst I; Riegger GA; Palkovits M
    Cardiovasc Res; 1997 Jun; 34(3):575-81. PubMed ID: 9231041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.